Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?

@article{Liao2010DistinguishingBP,
  title={Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?},
  author={Chiung-Ling Liao and J. Hsu and Ming-Yung Lee and L. Kok and Y. Li and P. Wang and Chung-Chin Yao and Chih-Ping Han},
  journal={Virchows Archiv},
  year={2010},
  volume={456},
  pages={377-386}
}
  • Chiung-Ling Liao, J. Hsu, +5 authors Chih-Ping Han
  • Published 2010
  • Biology, Medicine
  • Virchows Archiv
  • Gynecological pathologists are used to operating many panels of various markers in combination for the diagnostic distinction between primary endocervical and endometrial adenocarcinomas. The conventional 3-marker (ER/Vim/CEA) panel is the most promising tool. In this study, our aim is to investigate whether a 2-marker panel is enough to distinguish between these two gynecologic malignancies. Additionally, we wish to determine which one is the most favorable among eight panels tested, including… CONTINUE READING
    9 Citations
    Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas
    • 27
    P16INK4a Expression in Undifferentiated Carcinoma of the Uterus Does Not Exclude Its Endometrial Origin
    • R. Saad, M. Mashhour, +5 authors M. Khalifa
    • Medicine
    • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
    • 2012
    • 17
    • Highly Influenced
    Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome
    • 23
    • PDF
    Differential Vimentin Expression in Ovarian and Uterine Corpus Endometrioid Adenocarcinomas: Diagnostic Utility in Distinguishing Double Primaries from Metastatic Tumors
    • 10
    Clear cell carcinoma of the lower uterine segment: A case report
    • 1
    • PDF
    RAB8A a new biomarker for endometrial cancer?
    • 5

    References

    SHOWING 1-10 OF 29 REFERENCES
    Adding the p16INK4a Marker to the Traditional 3-marker (ER/Vim/CEA) Panel Engenders No Supplemental Benefit in Distinguishing Between Primary Endocervical and Endometrial Adenocarcinomas in a Tissue Microarray Study
    • Chih-Ping Han, Ming-Yung Lee, +5 authors C. Lin
    • Medicine
    • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
    • 2009
    • 12
    Immunohistochemical Staining in the Distinction Between Primary Endometrial and Endocervical Adenocarcinomas: Another Viewpoint
    • 113
    A Panel of Immunohistochemical Stains, Including Carcinoembryonic Antigen, Vimentin, and Estrogen Receptor, Aids the Distinction Between Primary Endometrial and Endocervical Adenocarcinomas
    • 168
    Distinction Between Endometrial and Endocervical Adenocarcinoma: An Immunohistochemical Study
    • D. Castrillon, K. Lee, M. Nucci
    • Biology, Medicine
    • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
    • 2002
    • 140
    p16 Immunoreactivity May Assist in the Distinction Between Endometrial and Endocervical Adenocarcinoma
    • W. G. McCluggage, D. Jenkins
    • Biology, Medicine
    • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
    • 2003
    • 132